Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP (IRMD) reports on the Annual Meeting of Stockholders held on June 10, 2022. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders voted on four proposals at the annual meeting:
- Director Elections: Stockholders elected Roger Susi, Monty Allen, Anthony Vuoto, and James Hawkins to the Board of Directors. Significant votes were withheld for Monty Allen (2,912,718) and Anthony Vuoto (2,326,738) compared to Roger Susi (1,931,789).
- Auditor Ratification: Stockholders ratified the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, with 11,379,731 votes for and 9,204 against.
- Executive Compensation (Say-on-Pay): Stockholders approved the advisory resolution on executive compensation with 10,235,323 votes for and 139,607 against.
- Frequency of Say-on-Pay Votes: Stockholders voted on an advisory basis to hold future advisory votes on executive compensation annually, with 10,287,164 votes for a 1-year frequency.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific reasons for the higher number of votes withheld for directors Monty Allen and Anthony Vuoto compared to other nominees.
- Confirm the tenure and background of the newly elected directors.
- Review the full proxy statement for details on the executive compensation package approved by stockholders.
- Check subsequent filings for the company's financial performance for the fiscal year ending December 31, 2022, as this 8-K does not contain financial data.